News
September 28, 2016
Ionis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Lifetime Achievement Award from the Oligonucleotide Therapeutics SocietySeptember 26, 2016
Biogen Completes Rolling Submission of New Drug Application to FDA for Nusinersen as a Treatment for Spinal Muscular Atrophy
Spotlight
CHMP of the EMA has Granted Nusinersen Accelerated Assessment
More »
Ionis Receives Drug Discovery Award to Support Cystic Fibrosis Research
More »
Newly Published Data Demonstrate a Novel Pro-inflammatory Mechanism for Lp(a) in Humans
More »
Newly Published Nusinersen Clinical Data Highlight Positive Data in Children with Spinal Muscular Atrophy
More »
Clinical Trials
We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »
Events
No upcoming events at this time...